 
  Revvity, Inc. operates in a competitive medical diagnostics and research industry with a focus on life sciences and diagnostic solutions. Although the company has shown steady performance, there are both opportunities and challenges ahead. The stock's fundamentals suggest a stable outlook with areas that could see improvement.
Revvity, Inc. holds a fundamental rating of 'B', with an overall score reflecting moderate potential for growth. The individual fundamental scores suggest balanced strengths but reveal potential improvement areas in financial leverage.
| Category | Score | Visualization | 
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 1 | |
| Price to Book | 3 | 
The historical ratings indicate a stable performance over the recent period, with a consistent understanding of fundamental strengths and challenges.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B | 
|---|---|---|---|---|---|---|---|
| 2025-08-29 | 3 | 4 | 3 | 4 | 2 | 1 | 3 | 
| Previous | 0 | 4 | 3 | 4 | 2 | 1 | 3 | 
Analysts provide a generally optimistic outlook with a median price target suggesting upside. The consensus is consistent with a 'Buy' recommendation.
| High | Low | Median | Consensus | 
|---|---|---|---|
| $140 | $110 | $128.5 | $128.5 | 
 
The sentiment from analysts supports a buy-side stance, with no significant sell pressure indicated in the ratings.
| Recommendation | Count | Visualization | 
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 12 | |
| Sell | 0 | |
| Strong Sell | 0 | 
Revvity, Inc. stands as a stable entity within the diagnostics market, backed by its solid fundamentals and support from analysts. However, some areas, particularly financial leverage, suggest room for improvement. The stock is generally favored by analysts, with price targets indicating potential upside. While competition remains a factor, Revvity's continued innovation and diverse offerings present opportunities for growth. Investors should weigh these insights within the broader market context when considering their investment strategy.